These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
261 related articles for article (PubMed ID: 22961067)
21. Chitosan-modified poly(D,L-lactide-co-glycolide) nanospheres for plasmid DNA delivery and HBV gene-silencing. Zeng P; Xu Y; Zeng C; Ren H; Peng M Int J Pharm; 2011 Aug; 415(1-2):259-66. PubMed ID: 21645597 [TBL] [Abstract][Full Text] [Related]
22. Non-aggregated protamine-coated poly(lactide-co-glycolide) nanoparticles of cisplatin crossed blood-brain barrier, enhanced drug delivery and improved therapeutic index in glioblastoma cells: in vitro studies. Dhami NK; Pandey RS; Jain UK; Chandra R; Madan J J Microencapsul; 2014; 31(7):685-93. PubMed ID: 24963955 [TBL] [Abstract][Full Text] [Related]
23. Paclitaxel loaded folic acid targeted nanoparticles of mixed lipid-shell and polymer-core: in vitro and in vivo evaluation. Zhao P; Wang H; Yu M; Liao Z; Wang X; Zhang F; Ji W; Wu B; Han J; Zhang H; Wang H; Chang J; Niu R Eur J Pharm Biopharm; 2012 Jun; 81(2):248-56. PubMed ID: 22446630 [TBL] [Abstract][Full Text] [Related]
24. Core-shell structured luminescent and mesoporous β-NaYF4:Ce3+/Tb3+@mSiO2-PEG nanospheres for anti-cancer drug delivery. Wu Y; Yang D; Kang X; Ma P; Huang S; Zhang Y; Li C; Lin J Dalton Trans; 2013 Jul; 42(27):9852-61. PubMed ID: 23689234 [TBL] [Abstract][Full Text] [Related]
26. Fabrication of core-shell microcapsules using PLGA and alginate for dual growth factor delivery system. Choi DH; Park CH; Kim IH; Chun HJ; Park K; Han DK J Control Release; 2010 Oct; 147(2):193-201. PubMed ID: 20647022 [TBL] [Abstract][Full Text] [Related]
27. Hybrid-modified poly(D,L-lactide-co-glycolide) nanospheres for a novel cellular drug delivery system. Tahara K; Furukawa S; Yamamoto H; Kawashima Y Int J Pharm; 2010 Jun; 392(1-2):311-3. PubMed ID: 20347023 [TBL] [Abstract][Full Text] [Related]
28. Bone metastasis targeting: a novel approach to reach bone using Zoledronate anchored PLGA nanoparticle as carrier system loaded with Docetaxel. Ramanlal Chaudhari K; Kumar A; Megraj Khandelwal VK; Ukawala M; Manjappa AS; Mishra AK; Monkkonen J; Ramachandra Murthy RS J Control Release; 2012 Mar; 158(3):470-8. PubMed ID: 22146683 [TBL] [Abstract][Full Text] [Related]
29. Development of disulfiram-loaded poly(lactic-co-glycolic acid) wafers for the localised treatment of glioblastoma multiforme: a comparison of manufacturing techniques. Zembko I; Ahmed I; Farooq A; Dail J; Tawari P; Wang W; Mcconville C J Pharm Sci; 2015 Mar; 104(3):1076-86. PubMed ID: 25537972 [TBL] [Abstract][Full Text] [Related]
30. Oral nuclear factor-κB decoy oligonucleotides delivery system with chitosan modified poly(D,L-lactide-co-glycolide) nanospheres for inflammatory bowel disease. Tahara K; Samura S; Tsuji K; Yamamoto H; Tsukada Y; Bando Y; Tsujimoto H; Morishita R; Kawashima Y Biomaterials; 2011 Jan; 32(3):870-8. PubMed ID: 20934748 [TBL] [Abstract][Full Text] [Related]
31. Nanosphere-mediated delivery of vascular endothelial growth factor gene for therapeutic angiogenesis in mouse ischemic limbs. Kang SW; Lim HW; Seo SW; Jeon O; Lee M; Kim BS Biomaterials; 2008 Mar; 29(8):1109-17. PubMed ID: 18022227 [TBL] [Abstract][Full Text] [Related]
32. Immunization against leishmaniasis by PLGA nanospheres loaded with an experimental autoclaved Leishmania major (ALM) and Quillaja saponins. Tafaghodi M; Eskandari M; Kharazizadeh M; Khamesipour A; Jaafari MR Trop Biomed; 2010 Dec; 27(3):639-50. PubMed ID: 21399606 [TBL] [Abstract][Full Text] [Related]
33. Paclitaxel delivery from PLGA foams for controlled release in post-surgical chemotherapy against glioblastoma multiforme. Ong BY; Ranganath SH; Lee LY; Lu F; Lee HS; Sahinidis NV; Wang CH Biomaterials; 2009 Jun; 30(18):3189-96. PubMed ID: 19285718 [TBL] [Abstract][Full Text] [Related]
34. Cancer therapy and fluorescence imaging using the active release of doxorubicin from MSPs/Ni-LDH folate targeting nanoparticles. Li D; Zhang YT; Yu M; Guo J; Chaudhary D; Wang CC Biomaterials; 2013 Oct; 34(32):7913-22. PubMed ID: 23886730 [TBL] [Abstract][Full Text] [Related]
35. Preparation of polylactide-co-glycolide nanoparticles incorporating celecoxib and their antitumor activity against brain tumor cells. Kim TH; Jeong YI; Jin SG; Pei J; Jung TY; Moon KS; Kim IY; Kang SS; Jung S Int J Nanomedicine; 2011; 6():2621-31. PubMed ID: 22114493 [TBL] [Abstract][Full Text] [Related]
36. Photochemical internalization for pDNA transfection: evaluation of poly(d,l-lactide-co-glycolide) and poly(ethylenimine) nanoparticles. Gargouri M; Sapin A; Arıca-Yegin B; Merlin JL; Becuwe P; Maincent P Int J Pharm; 2011 Jan; 403(1-2):276-84. PubMed ID: 21044878 [TBL] [Abstract][Full Text] [Related]
37. Development and characterization of hyaluronic acid-anchored PLGA nanoparticulate carriers of doxorubicin. Yadav AK; Mishra P; Mishra AK; Mishra P; Jain S; Agrawal GP Nanomedicine; 2007 Dec; 3(4):246-57. PubMed ID: 18068091 [TBL] [Abstract][Full Text] [Related]
38. Self-assembled oligopeptide nanostructures for co-delivery of drug and gene with synergistic therapeutic effect. Wiradharma N; Tong YW; Yang YY Biomaterials; 2009 Jun; 30(17):3100-9. PubMed ID: 19342093 [TBL] [Abstract][Full Text] [Related]
39. PLGA:poloxamer and PLGA:poloxamine blend nanoparticles: new carriers for gene delivery. Csaba N; Caamaño P; Sánchez A; Domínguez F; Alonso MJ Biomacromolecules; 2005; 6(1):271-8. PubMed ID: 15638530 [TBL] [Abstract][Full Text] [Related]
40. Nanoparticles of lipid monolayer shell and biodegradable polymer core for controlled release of paclitaxel: effects of surfactants on particles size, characteristics and in vitro performance. Liu Y; Pan J; Feng SS Int J Pharm; 2010 Aug; 395(1-2):243-50. PubMed ID: 20472049 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]